Related Experiment Video
Updated: Jun 9, 2025
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Research progress of exosomes in pathogenesis and treatment of preeclampsia
Yue Xing1,2, Luyao Kang1,2, Lu Chen1,2
1Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China.
Insights
Exosomes, tiny vesicles involved in cell communication, play a role in preeclampsia (PE) development. Studying these vesicles offers potential for early PE diagnosis, monitoring, and novel therapeutic strategies.
Area of Science:
- Obstetrics
- Cell Biology
- Biochemistry
Background:
- Preeclampsia (PE) is a severe obstetric condition with complex, poorly understood etiology and pathogenesis.
- Alterations in exosome characteristics and cargo are observed in PE patients.
- Exosomes are crucial for intercellular communication and have emerged as significant factors in various diseases.
Purpose of the Study:
- To review the role of exosomes in the etiology and pathogenesis of preeclampsia.
- To explore the potential of exosomes as diagnostic and prognostic biomarkers for PE.
- To investigate the therapeutic implications of targeting exosomes in PE management.
Main Methods:
- Systematic review of published literature on exosomes and preeclampsia.
Main Results:
- Exosomes influence endothelial and vascular function and maternal-fetal immune regulation.
- Exosomes transport microRNAs, long non-coding RNAs, and proteins implicated in PE development.
- Exosome content analysis aids in early PE diagnosis and monitoring.
Conclusions:
- Exosomes are implicated in PE pathogenesis and can serve as predictive markers for onset, disease tracking, and prognosis.
- Targeting exosomes presents a promising avenue for novel PE therapeutic interventions.
Aim:
Preeclampsia (PE) is a critical and severe disease in obstetrics, which seriously affects maternal and neonatal life safety and long-term prognosis. However, the etiology and pathogenesis of PE are complex, and no unified conclusion has been reached. The types and number of exosomes and their transport substances in PE patients changed. The study of exosomes in PE patients helps clarify the etiology, diagnosis, effective treatment, accurate monitoring, and prognosis.
Method:
The published articles were reviewed.
Results:
Exosomes may affect endothelial and vascular production and function, participate in maternal-fetal immune regulation, and transport substances such as miRNAs, lncRNAs, and proteins involved in the development of PE. Detection of the contents of exosomes can help in the early diagnosis of PE, and can help to improve PE by inhibiting the action of exosomes or preventing their binding to target organs.
Conclusion:
Exosomes may be involved in the development of PE, and exosomes can be used as markers for predicting the onset of PE and tracking the disease process and determining the prognosis, and exosomes have great potential in the treatment of PE.
